论文信息 - Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study - 字舞流文

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

D. Arnold | M. Freedman | J. Wolinsky | T. Ziemssen | A. Wundes | R. Naismith | M. Gudesblatt | N. Nangia | M. Lopez-Bresnahan | C. Laganke | B. Kandinov | Shifang Liu | D. Obradovic | Richard A Leigh-Pemberton | David Rezendes | J. Hanna | Lili Yang | I. Bidollari | Catherine Miller | Hailu Chen | Mark Gudesblatt